AV20538
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
100mg | 96% | in stock | $123.00 | $86.00 | - + | |
250mg | 96% | in stock | $206.00 | $144.00 | - + | |
1g | 96% | in stock | $482.00 | $337.00 | - + | |
5g | 96% | in stock | $1,570.00 | $1,099.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AV20538 |
Chemical Name: | 1-(2-Chloro-6-fluorophenyl)cyclopropane-1-carboxylic acid |
CAS Number: | 1006876-25-0 |
Molecular Formula: | C10H8ClFO2 |
Molecular Weight: | 214.6207 |
MDL Number: | MFCD11036974 |
SMILES: | Fc1cccc(c1C1(CC1)C(=O)O)Cl |
1-(2-Chloro-6-fluorophenyl)cyclopropanecarboxylic acid is a versatile compound commonly used in chemical synthesis. Its unique molecular structure makes it a valuable building block in the creation of various pharmaceuticals and agrochemicals. With its cyclopropane ring and functional groups, this compound serves as a key intermediate in the synthesis of bioactive molecules and complex organic compounds.In organic synthesis, 1-(2-Chloro-6-fluorophenyl)cyclopropanecarboxylic acid can participate in a range of reactions such as cross-coupling, nucleophilic substitution, and oxidation processes. Its cyclopropane core provides rigidity and steric constraints, which can influence the stereochemistry and reactivity of the resulting products. Furthermore, the presence of the chloro and fluoro substituents enhances the compound's reactivity and compatibility in various reaction conditions.This compound's utility extends to medicinal chemistry where it can be transformed into pharmacologically active agents through further derivatization. By incorporating 1-(2-Chloro-6-fluorophenyl)cyclopropanecarboxylic acid into drug design, researchers can access novel chemical scaffolds with diverse biological properties. Its versatile nature and synthetic accessibility make it a valuable asset in the development of new drugs and chemical probes in the pharmaceutical industry.